Prenatal Care — MCQs

An 18-year-old G2P1L1 with a last menstrual period of May 7 presents for her first OB visit at 10 weeks. The patient had a previous pregnancy complicated by gestational diabetes and delivered a 4.2kg baby boy via cesarean section after a long labor. Which of the following should NOT be performed at each routine prenatal visit?

Q70Medium

A 4-month pregnant lady on regular treatment with valproate asks for advice regarding continuing the drug during pregnancy. What is the best course of action?

Prenatal Care Indian Medical PG Practice Questions and MCQs

Question 61: When can heartbeat in a conceptus be detected earliest?

A. 4-6 weeks (Correct Answer)
B. 12-14 weeks
C. 14-16 weeks
D. 21-24 weeks

Explanation: ### Explanation **Correct Answer: A. 4-6 weeks** The development of the cardiovascular system is a critical milestone in early embryogenesis. The primitive heart begins to beat at approximately **21 to 22 days (3 weeks)** after fertilization. In clinical practice, pregnancy is dated from the Last Menstrual Period (LMP). Therefore, the fetal heartbeat can be detected via **Transvaginal Sonography (TVS)** as early as **5.5 to 6 weeks** of gestation. At this stage, the embryo is only 2–5 mm in length (Crown-Rump Length). **Why other options are incorrect:** * **B & C (12–16 weeks):** While the heartbeat is easily audible during this period using a **Handheld Doppler** (usually around 10–12 weeks) or a **Pinard stethoscope** (around 18–20 weeks), these do not represent the *earliest* detection possible. * **D (21–24 weeks):** This is far beyond the initial detection period. By this stage, the heartbeat is robust and can be felt through fetal movements (quickening) or seen on routine mid-trimester scans. **High-Yield Clinical Pearls for NEET-PG:** * **First organ to function:** The heart is the first functional organ to develop in the embryo. * **TVS vs. TAS:** Transvaginal Sonography (TVS) can detect the cardiac flicker at **6 weeks**, whereas Transabdominal Sonography (TAS) usually detects it by **7–8 weeks**. * **Discriminatory Zone:** If the Mean Sac Diameter (MSD) is **>25 mm** on TAS or **>16-20 mm** on TVS and no fetal pole/heartbeat is seen, it suggests a non-viable pregnancy (Blighted Ovum). * **Fetal Heart Rate (FHR):** Starts at approximately 110 bpm at 6 weeks, peaks at 170–180 bpm at 9 weeks, and stabilizes to 110–160 bpm in the second and third trimesters.

Question 62: For diagnosing chronic hypertension in pregnancy, hypertension is considered present prior to what gestational age?

A. 8 weeks
B. 14 weeks
C. 20 weeks (Correct Answer)
D. 24 weeks

Explanation: **Explanation:** The classification of hypertensive disorders in pregnancy is primarily based on the **gestational age** at the time of onset. **1. Why 20 weeks is correct:** In obstetrics, **20 weeks of gestation** is the critical diagnostic threshold. * **Chronic Hypertension:** Defined as high blood pressure (≥140/90 mmHg) that is present **before pregnancy** or diagnosed **before 20 weeks** of gestation. It typically persists beyond 12 weeks postpartum. * **Gestational Hypertension/Preeclampsia:** Hypertension that develops for the first time **after 20 weeks** of gestation is classified as gestational hypertension (if no proteinuria/end-organ damage) or preeclampsia (if proteinuria or systemic features are present). **2. Why other options are incorrect:** * **8 weeks and 14 weeks:** While hypertension present at these stages is indeed "chronic," they are not the formal diagnostic cutoff. The 20-week mark is used because physiological hemodilution and the second wave of trophoblastic invasion (which usually lowers BP) occur by this time; any hypertension persisting or appearing before this is attributed to pre-existing vascular pathology. * **24 weeks:** This is past the diagnostic window for chronic hypertension. New-onset hypertension at 24 weeks would be classified as gestational hypertension or preeclampsia. **High-Yield Clinical Pearls for NEET-PG:** * **The "Rule of 20":** Before 20 weeks = Chronic Hypertension; After 20 weeks = Gestational Hypertension/Preeclampsia. * **Exception:** Hydatidiform mole (Gestational Trophoblastic Disease) can cause preeclampsia **before** 20 weeks. * **Postpartum persistence:** If hypertension persists >12 weeks after delivery, the diagnosis is revised to Chronic Hypertension, regardless of when it was first detected. * **Drug of Choice:** Labetalol is generally the first-line antihypertensive in pregnancy; ACE inhibitors and ARBs are strictly **contraindicated** due to teratogenicity (renal dysgenesis).

Question 63: Prophylactic anti-D immunoglobulin is given to Rh-negative pregnant women antenatally at which gestational age?

A. 20 weeks
B. 24 weeks
C. 28 weeks (Correct Answer)
D. 32 weeks

Explanation: **Explanation:** The correct answer is **28 weeks (Option C)**. **Medical Concept:** Rh isoimmunization occurs when an Rh-negative mother is exposed to Rh-positive fetal red blood cells, leading to the production of anti-D antibodies. While most feto-maternal hemorrhages (FMH) occur at delivery, small "silent" bleeds can occur during the third trimester. Prophylactic administration of Anti-D immunoglobulin (RhoGAM) at **28 weeks** of gestation is the standard of care because the risk of sensitization increases significantly after this period. A single dose of 300 mcg (1500 IU) at 28 weeks provides coverage for the remainder of the pregnancy, as the half-life of the immunoglobulin is approximately 24 days. **Analysis of Incorrect Options:** * **A (20 weeks) & B (24 weeks):** These are too early. The risk of spontaneous FMH in an uncomplicated pregnancy is negligible before 28 weeks. Administering it this early would mean the passive antibodies would deplete before the high-risk delivery period. * **D (32 weeks):** This is too late. A significant number of women may already become sensitized between 28 and 32 weeks, rendering the prophylaxis ineffective if delayed. **High-Yield Clinical Pearls for NEET-PG:** * **Postpartum Dose:** If the neonate is Rh-positive, a second dose (300 mcg) must be given within **72 hours of delivery**. * **First Trimester Events:** For miscarriage, ectopic pregnancy, or CVS (<13 weeks), a lower dose of **50 mcg** is sufficient. * **Indirect Coombs Test (ICT):** Anti-D is only given if the mother is **non-sensitized** (ICT negative). If ICT is positive, the mother is already sensitized, and Anti-D is of no use. * **Kleihauer-Betke Test:** Used to quantify the volume of FMH to determine if additional doses of Anti-D are required beyond the standard 300 mcg.

Question 64: What is the typical Crown-Rump Length (CRL) at 12 weeks of gestation?

A. 60 mm (Correct Answer)
B. 100 mm
C. 120 mm
D. 250 mm

Explanation: **Explanation:** The **Crown-Rump Length (CRL)** is the most accurate clinical parameter for dating a pregnancy in the first trimester (up to 13 weeks + 6 days). It measures the length of the embryo or fetus from the top of the head (crown) to the bottom of the buttocks (rump). The correct answer is **60 mm**. At 12 weeks of gestation, the average CRL typically ranges between **54 mm and 60 mm**. A useful clinical "rule of thumb" for CRL is that at 12 weeks, the fetus is roughly 6 cm long. **Analysis of Options:** * **A (60 mm):** Correct. This aligns with standard fetal growth charts (e.g., Hadlock) for 12 weeks. * **B (100 mm):** Incorrect. This length is more characteristic of **15–16 weeks** of gestation. * **C (120 mm):** Incorrect. This corresponds to approximately **17–18 weeks**. * **D (250 mm):** Incorrect. This is much larger and would be seen in the **third trimester** (around 28–30 weeks). **High-Yield Clinical Pearls for NEET-PG:** 1. **Accuracy:** CRL is accurate for dating within **±3–5 days**. 2. **Timing:** It is measured between **7 and 14 weeks**. Once the CRL exceeds **84 mm** (approx. 14 weeks), Head Circumference (HC) and Biparietal Diameter (BPD) become the preferred biometric markers. 3. **Formula:** A quick bedside calculation for gestational age (GA) is: **GA (in weeks) = CRL (in cm) + 6.5**. 4. **Nuchal Translucency (NT):** The 11–13+6 week window (when CRL is 45–84 mm) is also the critical time for performing the NT scan to screen for aneuploidies like Trisomy 21.

Question 65: A hypertensive woman is seeking preconception counseling. Which of the following antihypertensive medications is advised to be continued once she becomes pregnant?

A. Enalapril
B. Chlorthalidone
C. Nifedipine (Correct Answer)
D. Losartan

Explanation: **Explanation:** The management of hypertension in pregnancy requires a careful balance between maternal benefit and fetal safety. **Nifedipine**, a long-acting Calcium Channel Blocker (CCB), is considered a first-line antihypertensive agent in pregnancy. It is preferred because it is non-teratogenic, does not affect uteroplacental blood flow significantly, and has a well-established safety profile for both chronic hypertension and the management of pre-eclampsia. **Analysis of Options:** * **Nifedipine (Correct):** Along with Labetalol and Methyldopa, Nifedipine is a mainstay of treatment. It is effective and safe to continue from the preconception period through delivery. * **Enalapril (Incorrect):** This is an ACE Inhibitor. ACE inhibitors are strictly contraindicated in pregnancy (Category D) as they cause **fetal renal dysgenesis**, oligohydramnios, skull hypoplasia, and intrauterine growth restriction (IUGR). * **Losartan (Incorrect):** This is an Angiotensin II Receptor Blocker (ARB). Like ACE inhibitors, ARBs interfere with the fetal renin-angiotensin system, leading to severe renal toxicity and fetopathy. * **Chlorthalidone (Incorrect):** Thiazide diuretics are generally avoided as first-line therapy in pregnancy because they can prevent the physiological plasma volume expansion necessary for a healthy pregnancy and may cause neonatal thrombocytopenia or electrolyte imbalances. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC)** for Chronic Hypertension in pregnancy: **Labetalol** (often preferred over Methyldopa due to fewer side effects). * **DOC for Acute Hypertensive Crisis** in pregnancy: **IV Labetalol** or **IV Hydralazine**. * **Safe drugs:** Labetalol, Methyldopa, Nifedipine, Hydralazine. * **Contraindicated drugs:** ACE inhibitors, ARBs, Nitroprusside (risk of cyanide toxicity), and Spironolactone (anti-androgenic effects).

Question 66: In triple screening test for Down's syndrome during pregnancy, which of the following is NOT included?

A. Serum beta hCG
B. Serum oestriol
C. Maternal serum Alfa fetoprotein
D. Acetyl cholinesterase (Correct Answer)

Explanation: ### Explanation The **Triple Screening Test** is a second-trimester maternal serum screening performed between **15 and 20 weeks** of gestation (ideally 16–18 weeks) to assess the risk of chromosomal abnormalities, primarily Down syndrome (Trisomy 21). #### Why Acetylcholinesterase is the Correct Answer **Acetylcholinesterase (AChE)** is not a component of the Triple Screen. It is a specific biochemical marker used to confirm **Neural Tube Defects (NTDs)**. When Maternal Serum Alpha-Fetoprotein (MSAFP) is elevated, an amniocentesis is performed; if the amniotic fluid AFP is also high, the presence of AChE in the amniotic fluid confirms an open NTD (like spina bifida or anencephaly), as it leaks from exposed neural tissue. #### Analysis of Incorrect Options (Components of Triple Screen) In a pregnancy affected by **Down Syndrome**, the typical "Triple Test" pattern is: * **Maternal Serum Alpha-fetoprotein (MSAFP):** Decreased. * **Serum Unconjugated Oestriol (uE3):** Decreased. * **Serum beta-hCG:** Increased. *(Note: If Inhibin-A is added to these three, it becomes the **Quadruple Screen**, which is the preferred second-trimester screening method due to higher sensitivity.)* #### High-Yield Clinical Pearls for NEET-PG * **Down Syndrome Pattern:** "HI" is high (hCG and Inhibin-A are **High**), while AFP and uE3 are **Low**. * **Edwards Syndrome (Trisomy 18):** All markers (AFP, hCG, uE3) are **decreased**. * **Timing:** The best time for the Triple/Quadruple screen is **15–20 weeks**. * **Combined Test:** Performed in the **first trimester** (11–13+6 weeks), consisting of Nuchal Translucency (NT) scan, PAPP-A (low in Down's), and beta-hCG (high in Down's).

Question 67: Cervical cerclage is offered to pregnant women with a prior history of preterm birth if the cervical length is less than?

A. 25mm (Correct Answer)
B. 30mm
C. 35mm
D. 40mm

Explanation: **Explanation:** The correct answer is **25mm**. This question tests the management of cervical insufficiency based on the **ACOG and RCOG guidelines** for ultrasound-indicated cerclage. **1. Why 25mm is Correct:** Cervical cerclage is indicated in women with a **singleton pregnancy** and a **history of spontaneous preterm birth** (before 34 weeks) if the transvaginal ultrasound (TVUS) reveals a cervical length of **<25mm** before 24 weeks of gestation. This threshold is used because a cervical length below the 10th percentile (25mm) significantly increases the risk of recurrent preterm birth, and cerclage has been proven to reduce this risk in this specific high-risk subgroup. **2. Why Incorrect Options are Wrong:** * **30mm, 35mm, and 40mm:** These measurements are considered within the normal range for cervical length during the second trimester. Intervening at these lengths would lead to unnecessary surgical procedures (over-treatment) without a documented benefit in preventing preterm delivery. **Clinical Pearls for NEET-PG:** * **Types of Cerclage:** * **History-indicated:** Performed at 12–14 weeks based on ≥3 prior preterm births or mid-trimester losses. * **Ultrasound-indicated:** Performed if length is <25mm in a woman with a prior preterm birth. * **Physical exam-indicated (Rescue/Emergency):** Performed when the cervix is already dilated/effaced with visible membranes. * **Contraindications:** Cerclage should not be performed if there is active labor, clinical chorioamnionitis, placental abruption, or lethal fetal anomalies. * **Surgical Techniques:** McDonald (most common) and Shirodkar (submucosal). * **Removal:** Usually performed at **36–37 weeks** of gestation or earlier if labor begins.

Question 68: What is the standard dose of Anti-D immunoglobulin?

A. 300 mg (Correct Answer)
B. 200 mg
C. 30 mg
D. 3 mg

Explanation: **Explanation:** The standard dose of Anti-D immunoglobulin (RhoGAM) for a full-term pregnancy is **300 µg (micrograms)**. It is administered to Rh-negative, unsensitized mothers to prevent Rh isoimmunization. **1. Why 300 µg is correct:** One standard dose of 300 µg of Anti-D is sufficient to neutralize **30 ml of fetal whole blood** (or 15 ml of fetal red blood cells) that may enter the maternal circulation during delivery. This dose is the global standard for routine postpartum prophylaxis (within 72 hours of delivery) and for routine antenatal prophylaxis at 28 weeks of gestation. **2. Why the other options are incorrect:** * **300 mg (Option A - Note on Units):** In clinical practice, the dose is 300 **micrograms (µg)**. While the question lists "mg," in the context of NEET-PG and standard textbooks (like DC Dutta), 300 is the numerical value students must identify. * **200 µg:** This is a sub-standard dose not used for full-term deliveries. * **50 µg (related to Option C/D):** A smaller dose of 50 µg is used specifically for first-trimester events (e.g., abortion or ectopic pregnancy) occurring before 12 weeks, as the fetal blood volume is much smaller. **High-Yield Clinical Pearls for NEET-PG:** * **Kleihauer-Betke Test:** Used to quantify the volume of feto-maternal hemorrhage (FMH). If the FMH exceeds 30 ml of whole blood, additional doses of Anti-D are required. * **Route:** Intramuscular (IM) is the standard route. * **Timing:** Must be given within **72 hours** of delivery for maximum efficacy, though it can be given up to 13–28 days if missed. * **Indirect Coombs Test (ICT):** Must be **negative** in the mother before administration (indicating she is not yet sensitized).

Question 69: An 18-year-old G2P1L1 with a last menstrual period of May 7 presents for her first OB visit at 10 weeks. The patient had a previous pregnancy complicated by gestational diabetes and delivered a 4.2kg baby boy via cesarean section after a long labor. Which of the following should NOT be performed at each routine prenatal visit?

A. Fetal heart tones by Doppler equipment
B. Real-time ultrasound for estimated fetal weight (Correct Answer)
C. Maternal blood pressure
D. Urinalysis

Explanation: **Explanation:** The goal of routine prenatal care is to monitor the health of the mother and fetus while identifying high-risk conditions early. However, the frequency and type of interventions must be evidence-based to avoid unnecessary costs and interventions. **Why Option B is Correct:** **Real-time ultrasound for estimated fetal weight (EFW)** is **not** indicated at every routine visit. In a low-risk pregnancy, a screening ultrasound is typically performed at 18–22 weeks (Anomaly Scan). Serial ultrasounds for growth are reserved for specific indications such as suspected Fetal Growth Restriction (FGR), macrosomia, or maternal complications (e.g., poorly controlled diabetes). Even in this patient, who has a history of a macrosomic baby (4.2kg) and gestational diabetes, growth is monitored via symphysis-fundal height (SFH) measurements starting at 20 weeks; ultrasound is used only if there is a clinical discrepancy. **Why Incorrect Options are Wrong:** * **Maternal Blood Pressure (C):** This is mandatory at every visit to screen for Preeclampsia and Gestational Hypertension. * **Urinalysis (D):** Performed at every visit (via dipstick) to screen for asymptomatic bacteriuria, proteinuria (preeclampsia), and glucosuria. * **Fetal Heart Tones (A):** Auscultation via Doppler (usually from 10–12 weeks onwards) is a standard component of every visit to confirm fetal viability and reassure the parents. **Clinical Pearls for NEET-PG:** * **Naegele’s Rule:** For this patient (LMP May 7), the EDD would be Feb 14. * **GDM Screening:** Because this patient has a history of GDM and a macrosomic baby, she should undergo an early OGT/GCT at the first visit rather than waiting until 24–28 weeks. * **Weight Gain:** Routine weighing at every visit is also a standard component of prenatal care.

Question 70: A 4-month pregnant lady on regular treatment with valproate asks for advice regarding continuing the drug during pregnancy. What is the best course of action?

A. Immediately stop valproate and start lamotrigine
B. Change to carbamazepine (Correct Answer)
C. Continue valproate and monitor blood levels
D. Slowly taper the dose of valproate

Explanation: **Explanation:** The management of epilepsy in pregnancy requires a delicate balance between seizure control and minimizing teratogenic risks. **Why Option B is Correct:** Sodium Valproate is the most teratogenic antiepileptic drug (AED), associated with a high risk of **Neural Tube Defects (NTDs)**, specifically spina bifida (1-2%), and neurodevelopmental delays. While the ideal time to switch medications is pre-conception, if a patient presents in the second trimester (4 months), the risk of valproate remains high. **Carbamazepine** is traditionally considered a safer alternative in pregnancy compared to valproate because it has a lower (though not zero) risk of major malformations. **Why Other Options are Wrong:** * **Option A:** "Immediately" stopping an AED is dangerous as it can trigger **status epilepticus**, which poses a severe hypoxic risk to the fetus. Lamotrigine is safe, but switching must be gradual. * **Option C:** Continuing valproate is avoided unless it is the *only* drug that controls the patient's seizures, as the structural and cognitive risks persist throughout pregnancy. * **Option D:** Tapering without adding a replacement drug leaves the mother unprotected against seizures. **High-Yield NEET-PG Pearls:** 1. **Drug of Choice (DOC):** For most epilepsies in pregnancy, **Lamotrigine** or **Levetiracetam** are now preferred over Carbamazepine due to superior safety profiles. However, based on traditional MCQ patterns, Carbamazepine is often the "safer" alternative provided. 2. **Folic Acid:** All pregnant women on AEDs should take **5 mg/day** of Folic Acid (starting pre-conception) to reduce NTD risk. 3. **Vitamin K:** Some authorities recommend 10 mg/day of Vitamin K in the last month of pregnancy for women on enzyme-inducing AEDs (like Carbamazepine) to prevent neonatal hemorrhage. 4. **Screening:** Patients exposed to Valproate must undergo a detailed **Level II Ultrasound** and maternal serum alpha-fetoprotein (MSAFP) testing.

Practice by Chapter

Preconception Counseling

Practice Questions

Pregnancy Diagnosis and Dating

Practice Questions

Routine Antenatal Assessments

Practice Questions

Maternal Physiological Changes

Practice Questions

Nutrition in Pregnancy

Practice Questions

Screening Tests in Pregnancy

Practice Questions

Fetal Growth Assessment

Practice Questions

High-Risk Pregnancy Identification

Practice Questions

Antenatal Complications Management

Practice Questions

Psychosocial Aspects of Pregnancy

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free